Group 1 - The core viewpoint of the news is the performance and holdings of the Fuqua Precision Medical Mixed A fund, which has shown significant returns over various time frames [1] - As of July 16, 2025, the latest net value of the fund is 3.3753 yuan, with a growth of 0.57% [1] - The fund's one-month return is 2.71%, ranking 1538 out of 2330 in its category; the six-month return is 56.76%, ranking 7 out of 2305; and the year-to-date return is 51.47%, ranking 11 out of 2296 [1] Group 2 - The top ten stock holdings of the Fuqua Precision Medical Mixed A fund account for a total of 69.71%, with the largest holdings being Baili Tianheng (9.66%), Haizike (9.65%), and Kelun Pharmaceutical (9.10%) [1] - The fund was established on November 16, 2017, and as of March 31, 2025, it has a total scale of 3.746 billion yuan [1] - The fund manager is Zhao Wei, who has extensive experience in the pharmaceutical and investment sectors [2]
7月16日富国精准医疗混合A净值增长0.57%,近6个月累计上涨56.76%
Sou Hu Cai Jing·2025-07-16 12:26